Karyopharm Therapeutics Inc.
KPTI
$7.46
$1.1518.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.02% | -52.93% | -43.21% | -35.90% | -35.75% |
| Total Receivables | -14.67% | 13.39% | 10.03% | -16.20% | 0.82% |
| Inventory | 43.61% | 72.23% | 55.73% | 50.47% | -5.34% |
| Prepaid Expenses | -42.37% | -33.55% | 13.24% | 10.59% | 18.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -95.45% | -93.94% | -94.36% |
| Total Current Assets | -53.07% | -39.39% | -33.10% | -29.81% | -28.43% |
|
|
|||||
| Total Current Assets | -53.07% | -39.39% | -33.10% | -29.81% | -28.43% |
| Net Property, Plant & Equipment | 40.17% | 30.20% | 28.72% | -43.80% | -37.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.81% | 2.20% | 0.43% | 30.57% | 323.26% |
| Total Assets | -50.99% | -37.54% | -31.62% | -29.81% | -28.15% |
|
|
|||||
| Total Accounts Payable | -7.15% | 16.79% | 63.53% | 513.26% | 22.30% |
| Total Accrued Expenses | 26.34% | 4.23% | -1.21% | -10.07% | -3.86% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 115.32% | -72.93% | -86.76% | 14.80% | 14.95% |
| Total Finance Division Other Current Liabilities | 7.15% | -4.76% | -0.79% | -13.06% | -16.07% |
| Total Other Current Liabilities | 7.15% | -4.76% | -0.79% | -13.06% | -16.07% |
| Total Current Liabilities | 72.19% | 38.31% | 32.79% | -0.94% | -2.22% |
|
|
|||||
| Total Current Liabilities | 72.19% | 38.31% | 32.79% | -0.94% | -2.22% |
| Long-Term Debt | -14.69% | -24.79% | -22.07% | -12.89% | -12.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 554.55% | 244.21% | 140.66% | -- | -78.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -45.06% | 225.68% | 1,434.97% | 1,548.39% | 840.99% |
| Total Liabilities | -0.67% | -10.66% | -6.96% | -5.73% | -6.22% |
|
|
|||||
| Common Stock & APIC | 1.20% | 1.87% | 1.98% | 2.06% | 2.15% |
| Retained Earnings | -8.23% | -4.10% | -5.14% | -6.05% | -6.37% |
| Treasury Stock & Other | 58.51% | 38.03% | -121.12% | 70.08% | 22.73% |
| Total Common Equity | -80.81% | -21.86% | -36.57% | -59.02% | -85.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -80.81% | -21.86% | -36.57% | -59.02% | -85.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -80.81% | -21.86% | -36.57% | -59.02% | -85.46% |
|
|
|||||